Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 208683
Company: SUN PHARMA CANADA
Company: SUN PHARMA CANADA
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE | 3.75%;EQ 1.2% BASE | GEL;TOPICAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 06/05/2018 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
GEL;TOPICAL; 3.75%;EQ 1.2% BASE
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE | 3.75%;EQ 1.2% BASE | GEL;TOPICAL | Prescription | No | AB | 209610 | PADAGIS ISRAEL |
| CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE | 3.75%;EQ 1.2% BASE | GEL;TOPICAL | Prescription | No | AB | 208683 | SUN PHARMA CANADA |
| ONEXTON | BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE | 3.75%;EQ 1.2% BASE | GEL;TOPICAL | Prescription | Yes | AB | 050819 | BAUSCH |